What's better than momentum? Mo' momentum.
Let's take a closer look at five of this past week's biggest scorchers.
|
Company |
July 27 Price |
Weekly Gain |
My Watchlist |
|---|---|---|---|
|
Sarepta Therapeutics |
$8.46 | 134% | Add |
|
InvenSense |
$12.93 | 32% | Add |
|
Nevsun Resources |
$3.74 | 29% | Add |
|
Lumber Liquidators |
$44.09 | 29% | Add |
|
Riverbed Technology |
$18.34 | 20% | Add |
Source: Barron's.
Sarepta Therapeutics was last week's biggest winner, more than doubling on encouraging study results for its experimental muscular dystrophy drug.
Talk about perfect timing! On Monday I singled out InvenSense as one of five stocks under $10 worth buying. A blowout quarterly report two days later pushed the motion-based controller specialist into the double digits. Widening adoption of its Motion Interface offerings by smartphones and tablets finds InvenSense issuing guidance for stronger-than-expected sequential growth in the current quarter.
Gold and copper miner Nevsun Resources struck it rich after announcing increased base-metals reserves at its majority-owned Bisha Mine in Eritrea.
Lumber Liquidators made skeptics walk the plank, posting better-than-expected quarterly results. Net sales rose 20% as the hardwood flooring retailer's stores came through with a 12.4% spike in comps. Earnings more than doubled, blowing past Wall Street's estimates.
Finally, we had Riverbed Technology post encouraging financials. The WAN optimization specialist also posted an encouraging near-term outlook.
More winners for you
It was a great week for these five stocks. If you want to get an early read on some of tomorrow's major gainers, there's a special report on three hidden winners in a booming industry. The report is free -- like this article -- but it won't be around forever, so check it out now.
